4//SEC Filing
Wiley Matthew T. 4
Accession 0001209191-21-024412
CIK 0001566044other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 12:15 PM ET
Size
5.1 KB
Accession
0001209191-21-024412
Insider Transaction Report
Form 4
Wiley Matthew T.
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2021-03-31$6.84/sh−2,573$17,599→ 114,397 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001759703
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 12:15 PM ET
- Size
- 5.1 KB